September Westbrook
Pediatrics · Little Rock, ARNPI 1093779415
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $685 and has fallen 54.5% since, to $312 in 2025. Among pediatrics clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $20.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$512
- Pfizer$402
- Corium, LLC$394
- Ironshore Pharmaceuticals Inc.$253
- GSK$243
- Merck$178
- plus $809 from 20 others
What the payments were for
- Food & beverage$2,72197%
- Education$703%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 13 | $512 |
| Pfizer | 20 | $402 |
| Corium, LLC | 15 | $394 |
| Ironshore Pharmaceuticals Inc. | 15 | $253 |
| GSK | 14 | $243 |
| Merck | 11 | $178 |
| Ultragenyx Pharmaceutical Inc. | 5 | $112 |
| Sanofi Pasteur Inc. | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $86 |
| Sanofi-aventis U.S. LLC | 4 | $84 |
| AstraZeneca | 3 | $53 |
| Phadia US Inc. | 3 | $52 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| Sanofi | 2 | $47 |
| Shire North American Group Inc | 3 | $39 |
| Kaleo, Inc. | 2 | $29 |
| Tris Pharma Inc | 2 | $27 |
| Biomarin Pharmaceutical Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| AbbVie | 1 | $18 |
| Neurelis, Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Sobi, Inc | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $12 |
| Mayne Pharma Commercial LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$244
How this compares
$2,791 in reported general payments places this provider in the 95th percentile of 464 pediatrics providers in Arkansas.
Other pediatrics in Little Rock
- Robert PesekLittle Rock$20K
- Peyton MillsLittle Rock$7K
- Eduardo OchoaLittle Rock$4K
- Laura MarrattLittle Rock$4K
- Lindsey HaackLittle Rock$2K
- Jerry ByrumLittle Rock$2K
- Dawn MartinLittle Rock$2K
- Joshua LyonLittle Rock$2K
- Anna OstromLittle Rock$2K
- Jessica EmisonLittle Rock$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.